Announcement

Collapse
No announcement yet.

FDA Approves First Treatment for Ebola Virus

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • FDA Approves First Treatment for Ebola Virus

    FDA NEWS RELEASE
    October 14, 2020

    Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.

    “Today’s action demonstrates the FDA’s ongoing commitment to responding to public health threats—both domestically and abroad—on the basis of science and data,” said FDA Commissioner Stephen M. Hahn, M.D. “This approval was made possible because of our steadfast dedication to facilitate the development of safe and effective treatments for infectious diseases as part of our vital public health mission.”

    Zaire ebolavirus, commonly known as Ebola virus, is one of four Ebolavirus species that can cause a potentially fatal human disease.

    Today, the FDA approved Inmazeb as the first FDA-approved treatment for Ebola virus infection in adult and pediatric patients.
Working...
X